Nuvation Bio NUVB
NYSE NUVB
$4.32 +0.12 (+2.74%)
As of: Nov 11, 2026 · 10:55 AM EST

Nuvation Bio (NUVB) Long-Term Investments (2020)

Updated

Nuvation Bio's Long-Term Investments was $143.76 million in Q4 2020, unchanged from the prior quarter.

Analysis

Nuvation Bio (NUVB) Long-Term Investments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Nuvation Bio 1.46 Bn -931.95 Mn 42.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 143.76 Mn
Sep 30, 2020 143.75 Mn
API Access

Nuvation Bio Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NUVB&period=max&api_key=YOUR_API_KEY